Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: Invalidity of the antibodies for tumor angiogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 86, Issue 24, 1989, Pages 9911-9915

  Matsuzaki, K ^a   Yoshitake, Y ^a   Matuo, Y ^a   Sasaki, H ^a   Nishikawa, K ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Monoclonal antibody

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY; TUMOR ANGIOGENESIS FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CATTLE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, MONOCLONAL; CATTLE; CELL DIVISION; CELL LINE; CELLS, CULTURED; CROSS REACTIONS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HEPARIN; HUMAN; HYBRIDOMAS; MICE; MICE, INBRED BALB C; MITOGENS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0024844291     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.86.24.9911     Document Type: Article

References (0)